Outset Medical Price to Sales Ratio 2019-2024 | OM

Historical PS ratio values for Outset Medical (OM) over the last 10 years. The current P/S ratio for Outset Medical as of May 09, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Outset Medical P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-05-09 15.30 0.46
2024-12-31 16.65 $33.23 0.50
2024-09-30 10.16 $33.95 0.30
2024-06-30 57.75 $34.55 1.67
2024-03-31 33.30 $37.68 0.88
2023-12-31 81.15 $39.67 2.05
2023-09-30 163.20 $40.41 4.04
2023-06-30 328.05 $39.94 8.21
2023-03-31 276.00 $36.74 7.51
2022-12-31 387.30 $36.10 10.73
2022-09-30 238.95 $35.40 6.75
2022-06-30 222.90 $35.22 6.33
2022-03-31 681.00 $35.65 19.10
2021-12-31 691.35 $34.04 20.31
2021-09-30 741.60 $40.59 18.27
2021-06-30 749.70 $48.89 15.34
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.055B $0.114B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.567B 53.27
Hims & Hers Health (HIMS) United States $11.630B 120.84
Tempus AI (TEM) United States $10.569B 0.00
Inspire Medical Systems (INSP) United States $4.461B 69.70
IRhythm Technologies (IRTC) United States $4.396B 0.00
Privia Health (PRVA) United States $3.035B 208.50
Enovis (ENOV) United States $1.887B 10.53
Clover Health Investments (CLOV) United States $1.793B 0.00
Schrodinger (SDGR) United States $1.746B 0.00
Phreesia (PHR) United States $1.506B 0.00
Azenta (AZTA) United States $1.223B 56.96
Omnicell (OMCL) United States $1.208B 21.31
10x Genomics (TXG) United States $1.073B 0.00
Fulgent Genetics (FLGT) United States $0.600B 0.00
Butterfly Network (BFLY) United States $0.551B 0.00
Talkspace (TALK) United States $0.509B 151.00
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.371B 827.00
Claritev (CTEV) United States $0.351B 0.00
Health Catalyst (HCAT) United States $0.290B 0.00
Nyxoah SA (NYXH) Belgium $0.215B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.136B 0.00
American Well (AMWL) United States $0.107B 0.00
Retrieve Medical Holdings (RMHI) United States $0.089B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
CareCloud (CCLD) United States $0.081B 3.07
111 (YI) China $0.068B 0.00
P3 Health Partners (PIII) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.060B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00